Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is set to enhance its corporate governance by amending its Articles of Association, particularly focusing on the operation of independent directors and special board committees. This move aligns with new regulatory requirements introduced by the China Securities Regulatory Commission, aiming to optimize the governance structure and improve standardization. The proposed amendments, which are detailed in a separate announcement, affect several chapters related to the roles and responsibilities of independent directors and the audit committee.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
